Avapag — Avatrombopag 20 mg, 28 product-page.units_short, Everest
100% original product

Avapag Tablets — Avatrombopag 20 mg (28 Tabs) Everest

7022 8339 -16%

Avapag 20 mg (Avatrombopag) is a second-generation thrombopoietin receptor agonist (TPO-RA) and a generic equivalent to Doptelet. It mimics biological thrombopoietin to stimulate the proliferation and differentiation of megakaryocytes in the bone marrow, resulting in increased platelet production.

Manufacturer: Everest Pharmaceuticals (Bangladesh). It offers a reliable solution for raising platelet counts without the need for platelet transfusions or immunosuppression.

Key Features:

  • Targeted Action: Specifically boosts platelet count to safe levels for surgeries or daily life.
  • Oral Convenience: Tablet formulation taken with food.
  • Dual Indication: Approved for both chronic liver disease (CLD) patients undergoing procedures and chronic immune thrombocytopenia (ITP).

Prescribed by hematologists/hepatologists for adult patients with:

  • 🔹 Chronic Liver Disease (CLD): Treatment of thrombocytopenia in patients scheduled to undergo an invasive procedure (to reduce the need for platelet transfusions).
  • 🔹 Chronic Immune Thrombocytopenia (ITP): Treatment of patients who have had an insufficient response to a previous treatment.

Sales Unit: Bottle containing 28 film-coated tablets (20 mg strength).

⚠️ APPLICATION INSTRUCTIONS:

  • Administration: Take orally with food (essential for efficacy). Swallow whole.
  • For CLD (Pre-procedure): Usually a 5-day course beginning 10-13 days before the scheduled procedure. Dosage (40 mg or 60 mg daily) depends on the baseline platelet count.
  • For Chronic ITP: Starting dose is typically 20 mg once daily. The doctor will adjust the dose to maintain platelet counts ≥ 50×10⁹/L.
  • Missed Dose: Take as soon as possible with food. Do not double the next dose.
  • Pregnancy & Breastfeeding: Not recommended due to potential fetal harm.
  • Hypersensitivity to Avatrombopag.
  • History of thromboembolic events (requires careful risk assessment).
  • Pediatric patients (safety not established).

Monitoring of platelet counts is mandatory. Potential side effects include:

  • ⚠️ Thromboembolism: Excessive platelet increase may cause blood clots. Seek help if you experience leg swelling, chest pain, or shortness of breath.
  • 🤯 Neurological: Headache, fatigue.
  • 🦴 Musculoskeletal: Joint pain (arthralgia).
  • 🤢 Gastrointestinal: Nausea, abdominal pain.
Active ingredient
Manufacturer
Everest
Dosage 20 mg
Dosage form Tablets
Tablets per pack 28
100% original product
Delivery across Ukraine
Customer reviews

What Customers Say

No reviews yet

Your review can be the first!

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00